Turkish specialists estimate CoronaVac effectiveness at 83.5%
Region
- 03 March, 2021
- 12:06
Turkish doctors estimate the effectiveness of the Chinese CoronaVac vaccine at 83.5%, Report informs, citing Turkey's Hacettepe University.
The third phase of vaccine trials began in Turkey in October. The study results also showed that the drug reduces the risk of hospitalization by 100%.
Meanwhile, Sinovac Biotech, the manufacturer, estimates the drug’s effectiveness at 62.3% after two doses. The interval between the doses should be 28 days.
Turkey began mass vaccination of the population against coronavirus on Jan. 14.
Latest News
15:16
Photo
SOCAR, ILO review potential collaboration prospects
Energy15:08
Estonia to open embassy in Azerbaijan in 2026
Foreign policy15:05
Azerbaijani MFA: Estonian companies eager to operate in Azerbaijan
Business14:55
Samsung dominated Azerbaijan's mobile device market in November
ICT14:46
Azerbaijan, Türkiye strengthen disaster risk reduction cooperation
Foreign policy14:46
Fitch Ratings updates economic growth forecast for Azerbaijan in 2025
Finance14:42
Portuguese President Rebelo de Sousa hospitalised following emergency surgery
Other countries14:34
Photo
ASAN AI Hub platform presented in Baku
Domestic policy14:04